MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2019 International Congress

    Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

    AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)

    Objective: To test whether the reintroduction of Botulinum Toxin Injections (BTI) after Globus pallidus interna Deep Brain Stimulation (Gpi-DBS) for intractable cervical dystonia synergistically improves…
  • 2019 International Congress

    The effect of Kinesio Taping therapy on Cervical Dystonia

    J. Magalhães, A. Rosso, F. Rezende (Rio de Janeiro, Brazil)

    Objective: To test the efficacy of kinesio taping treatment   as an adjunct therapy to botulinum toxin in the treatment of cervical dystonia. Background: Botulinum toxin…
  • 2019 International Congress

    Altered sensory processing in somatosensory and auditory domains in laryngeal dystonia

    T. Mantel, C. Dresel, M. Welte, C. Zimmer, B. Haslinger (Munich, Germany)

    Objective: To delineate correlates of altered sensory processing in laryngeal dystonia (LD) in both presence and absence of somatosensory input and their modulation by botulinum…
  • 2019 International Congress

    Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India

    S. Mehta, S. Ray, V. Lal (Chandigarh, India)

    Objective: To identify the clinical profile and treatment response patterns in patients with truncal dystonia. Background: Truncal Dystonia is characterized by involuntary contractions and postures…
  • 2019 International Congress

    Task Specific Dystonia and Its Response to Botulinum Neurotoxin Treatment

    R. Ortiz, T. Mertsalmi, F. Scheperjans, E. Pekkonen (Helsinki, Finland)

    Objective: To study the clinical features in task specific dystonia and its response to botulinum neurotoxin (BoNT) treatment. Background: Task specific dystonia is rare form…
  • 2019 International Congress

    Positive response to Botulinum Toxin injections in a patient with Painless Hand with Moving Fingers: A Case Report and Literature Review

    Z. Rosensweet, A. Persaud, E. Gaitour, N. Shneyder (Jacksonville, FL, USA)

    Objective: Objective: We present a rare case and literature review of Painless Hand with Moving Fingers (PHMF) that adequately responded to Onabotulinum toxin A (Botox)…
  • 2019 International Congress

    Classification of idiopathic cervical dystonia: an observational study

    P. Tater, N. Sarma, S. Pandey (New Delhi, India)

    Objective: The aim of our study was to classify patients with idiopathic cervical dystonia who had never been injected botulinum toxin. Background: Idiopathic cervical dystonia…
  • 2019 International Congress

    High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To assess safety, therapeutic response and long-term benefit of higher dose Onabotulinum toxin A (OnaA). Background: Botulinum toxin therapy is a powerful tool for…
  • 2019 International Congress

    Effect of Botulinum Toxin Treatment on Cervical Dystonia

    S. Tomic, M. Tomasevic, D. Hardi, T. Gilman Kuric, Z. Popovic (Osijek, Croatia)

    Objective: To find out influence of botulinum toxin (BonT) treatment on improvement of motor symptoms and pain.To find out influence of botulinum toxin (BonT) treatment…
  • 2019 International Congress

    Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.

    M. Velez, C. Cosentino, L. Torres (Lima, Peru)

    Objective: To update the experience with botulinum toxin type A therapy at the Unidad de Movimientos Involuntarios (UMI) of Instituto Nacional de Ciencias Neurologicas (INCN)-Lima,…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley